Company Focus on Transformational Milestones VANCOUVER, BC / ACCESSWIRE / November 28, 2022 / RepliCel Life Sciences Inc. (TSXV:RP) (OTC PINK:REPCF) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to provide the following corporate update. Dear Shareholders and Stakeholders, RepliCel is pleased to announce that Andrew Schutte has accepted the role of... Read More